Skip to main content
Clinical Trials/PACTR202203869312307
PACTR202203869312307
Not yet recruiting
Phase 1

Evaluation of an audit and feedback intervention to Reduce Gentamicin Prescription Errors in Newborn Treatment (ReGENT) in neonatal inpatient care in Kenya: A controlled interrupted time series study protocol

KEMRI Wellcome Trust Research Programme0 sites8,280 target enrollmentMarch 14, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
KEMRI Wellcome Trust Research Programme
Enrollment
8280
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 14, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Referral\-level hospitals with:
  • (1\) high quality gentamicin prescription baseline clinical data for neonatal inpatient care and,
  • (2\) a standardised A\&F routine clinical improvement cycle to track prescribing practices in neonatal inpatient care are eligible for inclusion in this study.
  • All neonates admitted to the newborn units in these hospitals with a gentamicin prescription at admission will be included in the study.

Exclusion Criteria

  • Referral\-level hospitals without 12 months worth of high quality gentamicin prescription baseline clinical data for neonatal inpatient care and without a standardised A\&F routine clinical improvement cycle to track prescribing practices in neonatal inpatient care are not eligible for inclusion in this study. All neonates admitted to the newborn units in these hospitals with missing data on gentamicin prescription at admission will be excluded from this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials